Volume-Based Quantitative Measurement of [18F]AlF-NOTA-FAPI-04 PET/CT Uptake Reflects the Disease Activity of IgG4-Related Disease

Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A et al (2020) The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis 79(1):77–87

Article  CAS  PubMed  Google Scholar 

Tang J, Cai S, Ye C, Dong L (2020) Biomarkers in IgG4-related disease: A systematic review. Semin Arthritis Rheum 50(2):354–359

Article  CAS  PubMed  Google Scholar 

Ren H, Mori N, Sato S, Mugikura S, Masamune A, Takase K (2022) American College of Rheumatology and the European League Against Rheumatism classification criteria for IgG4-related disease: an update for radiologists. Jpn J Radiol 40(9):876–893

Article  CAS  PubMed  Google Scholar 

Scarsbrook AF, Barrington SF (2016) PET-CT in the UK: current status and future directions. Clin Radiol 71(7):673–690

Article  CAS  PubMed  Google Scholar 

Wan L, Gao Y, Gu J, Chi H, Wang Z, Hu Q, Jia J, Liu T, Li B, Teng J et al (2021) Total metabolic lesion volume of lymph nodes measured by (18)F-FDG PET/CT: a new predictor of macrophage activation syndrome in adult-onset Still’s disease. Arthritis Res Ther 23(1):97

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rehak Z, Sprlakova-Pukova A, Kazda T, Fojtik Z, Vargova L, Nemec P (2017) (18)F-FDG PET/CT in polymyalgia rheumatica-a pictorial review. Br J Radiol 90(1076):20170198

Article  PubMed  PubMed Central  Google Scholar 

Kim K, Kim SJ (2021) (18)F-FDG PET/CT for assessing of disease activity of idiopathic inflammatory myopathies. A systematic review and meta-analysis. Hell J Nucl Med 24(2):132–139

PubMed  Google Scholar 

Yabusaki S, Oyama-Manabe N, Manabe O, Hirata K, Kato F, Miyamoto N, Matsuno Y, Kudo K, Tamaki N, Shirato H (2017) Characteristics of immunoglobulin G4-related aortitis/periaortitis and periarteritis on fluorodeoxyglucose positron emission tomography/computed tomography co-registered with contrast-enhanced computed tomography. EJNMMI Res 7(1):20

Article  PubMed  PubMed Central  Google Scholar 

Zhang J, Chen H, Ma Y, Xiao Y, Niu N, Lin W, Wang X, Liang Z, Zhang F, Li F et al (2014) Characterizing IgG4-related disease with 18F-FDG PET/CT: a prospective cohort study. Eur J Nucl Med Mol Imaging 41(8):1624–1634

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsuji S, Iwamoto N, Horai Y, Fujikawa K, Fujita Y, Fukui S, Ideguchi R, Michitsuji T, Nishihata S, Okamoto M et al (2021) Comparison of the quantitative measurement of 18F-FDG PET/CT and histopathological findings in IgG4-related disease. Clin Exp Rheumatol 39(6):1338–1344

Article  PubMed  Google Scholar 

Mitamura K, Arai-Okuda H, Yamamoto Y, Norikane T, Takami Y, Fujimoto K, Wakiya R, Ozaki H, Dobashi H, Nishiyama Y (2020) Disease activity and response to therapy monitored by [(18)F]FDG PET/CT using volume-based indices in IgG4-related disease. EJNMMI Res 10(1):153

Article  CAS  PubMed  PubMed Central  Google Scholar 

Orozco-Gálvez O, Fernández-Codina A, Simó-Perdigo M, Pinal-Fernández I, Martínez-Valle F (2021) Response to Treatment in IgG4-Related Disease Assessed by Quantitative PET/CT Scan. Clin Nucl Med 46(6):e307–e311

Article  PubMed  Google Scholar 

Berti A, Della-Torre E, Gallivanone F, Canevari C, Milani R, Lanzillotta M, Campochiaro C, Ramirez GA, Bozzalla Cassione E, Bozzolo E et al (2017) Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease. Rheumatology (Oxford) 56(12):2084–2092

Article  CAS  PubMed  Google Scholar 

Sharma P, Singh SS, Gayana S (2021) Fibroblast Activation Protein Inhibitor PET/CT: A Promising Molecular Imaging Tool. Clin Nucl Med 46(3):e141–e150

Article  PubMed  Google Scholar 

Dendl K, Koerber SA, Kratochwil C, Cardinale J, Finck R, Dabir M, Novruzov E, Watabe T, Kramer V, Choyke PL et al (2021) FAP and FAPI-PET/CT in malignant and non-malignant diseases: a perfect symbiosis? Cancers (Basel) 13(19):4946

Article  CAS  PubMed  Google Scholar 

Schmidkonz C, Rauber S, Atzinger A, Agarwal R, Götz TI, Soare A, Cordes M, Prante O, Bergmann C, Kleyer A et al (2020) Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging. Ann Rheum Dis 79(11):1485–1491

Article  CAS  PubMed  Google Scholar 

Luo Y, Pan Q, Yang H, Peng L, Zhang W, Li F (2021) Fibroblast Activation Protein-Targeted PET/CT with (68)Ga-FAPI for Imaging IgG4-Related Disease: Comparison to (18)F-FDG PET/CT. J Nucl Med 62(2):266–271

Article  CAS  PubMed  Google Scholar 

Mori Y, Haberkorn U, Giesel FL (2023) (68)Ga- or (18)F-FAPI PET/CT-what it can and cannot. Eur Radiol 33(11):7877–7878

Article  PubMed  PubMed Central  Google Scholar 

Hu K, Wang L, Wu H, Huang S, Tian Y, Wang Q, Xiao C, Han Y, Tang G (2022) [(18)F]FAPI-42 PET imaging in cancer patients: optimal acquisition time, biodistribution, and comparison with [(68)Ga]Ga-FAPI-04. Eur J Nucl Med Mol Imaging 49(8):2833–2843

Article  CAS  PubMed  Google Scholar 

Wallace ZS, Zhang Y, Perugino CA, Naden R, Choi HK, Stone JH (2019) Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis 78(3):406–412

Article  CAS  PubMed  Google Scholar 

Wallace ZS, Khosroshahi A, Carruthers MD, Perugino CA, Choi H, Campochiaro C, Culver EL, Cortazar F, Della-Torre E, Ebbo M et al (2018) An International Multispecialty Validation Study of the IgG4-Related Disease Responder Index. Arthritis Care Res (Hoboken) 70(11):1671–1678

Article  CAS  PubMed  Google Scholar 

Sun F, Wang C, Feng H, Yu F, Zhang X, Zhang P, Du X (2023) Visualization of Activated Fibroblasts in Heart Failure with Preserved Ejection Fraction with [(18)F]AlF-NOTA-FAPI-04 PET/CT Imaging. Mol Pharm 20(5):2634–2641

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang X (2014) Firth logistic regression for rare variant association tests. Front Genet 5:187

Article  PubMed  PubMed Central  Google Scholar 

Pan Q, Luo Y, Zhang W (2020) Recurrent Immunoglobulin G4-Related Disease Shown on 18F-FDG and 68Ga-FAPI PET/CT. Clin Nucl Med 45(4):312–313

Article  PubMed  Google Scholar 

Zhang H, Pan Q, Luo Y (2023) Prominent 68 Ga-FAPI Uptake in Renal Parenchyma Caused by Immunoglobulin G4-Related Nephropathy. Clin Nucl Med 48(5):463–465

Article  PubMed  Google Scholar 

Luo Y, Pan Q, Zhang W (2019) IgG4-related disease revealed by (68)Ga-FAPI and (18)F-FDG PET/CT. Eur J Nucl Med Mol Imaging 46(12):2625–2626

Article  PubMed  Google Scholar 

Shou Y, Xue Q, Yuan J, Zhao J (2021) (68)Ga-FAPI-04 PET/MR is helpful in differential diagnosis of pancreatitis from pancreatic malignancy compared to (18)F-FDG PET/CT: a case report. Eur J Hybrid Imaging 5(1):12

Article  PubMed  PubMed Central  Google Scholar 

Bai Z, Zhou T, Yu Z, Chen Y, Dong L (2022) Clinical value of (18)F-FDG PET/CT in IgG4-related disease. Ann Nucl Med 36(7):651–660

Article  CAS  PubMed  Google Scholar 

Kamisawa T, Zen Y, Pillai S, Stone JH (2015) IgG4-related disease. Lancet 385(9976):1460–1471

Article  CAS  PubMed  Google Scholar 

Lanzillotta M, Mancuso G, Della-Torre E (2020) Advances in the diagnosis and management of IgG4 related disease. BMJ 369:m1067

Article  PubMed 

留言 (0)

沒有登入
gif